Desq Long
Sign in

Company

MADRIGAL PHARMACEUTICALS, INC.

MDGL · CIK 0001157601

SEC FORM 4
$31,985.48

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 60 shares at $533.0913 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$56,610.68

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 106 shares at $534.063 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$116,835.68

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 218 shares at $535.9435 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$86,018.80

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 160 shares at $537.6175 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$371,382.38

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 687 shares at $540.5857 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$199,324.37

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 368 shares at $541.6423 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$652,209.05

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 1,202 shares at $542.6032 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$837,252.94

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 1,539 shares at $544.024 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$414,616.16

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 761 shares at $544.8307 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$65,565.20

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 120 shares at $546.3767 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$69,152.06

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 131 shares at $527.8783 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$279,914.49

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 520 shares at $538.2971 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$115,891.04

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 215 shares at $539.0281 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$272,796.40

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 505 shares at $540.1909 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$196,078.68

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 362 shares at $541.6538 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$86,807.60

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 160 shares at $542.5475 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$183,655.68

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 347 shares at $529.2671 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$276,780.63

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 522 shares at $530.2311 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$195,772.21

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 368 shares at $531.9897 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$272,943.72

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 512 shares at $533.0932 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$211,541.77

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 396 shares at $534.1964 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$344,715.10

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 644 shares at $535.2719 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$557,556.79

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 1,040 shares at $536.1123 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$343,791.23

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 640 shares at $537.1738 per share.

Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →

SEC FORM 4
$341,940.08

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Sale of 664 shares at $514.97 per share.

Reporting Person Kelley Shannon T · Officer Title General Counsel · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 20, 2026FILED +3 DAYS

Source: SEC Form 4 · 0001628280-26-058256 · filed 2026-08-20 · View filing →

SEC FORM 4
$0.00

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Acquisition (code A) of 647 shares at $0 per share.

Reporting Person REED JOHN C · Transaction Code A

Traded Aug 15, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001628280-26-057751 · filed 2026-08-18 · View filing →